(Q40653601)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27240464%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

title

Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27240464%20AND%20SRC:MED&resulttype=core&format=json

Middle East respiratory syndrome coronavirus

3 April 2020

main subject

0 references

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27240464%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

Kian-Pin Tan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27240464%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Ying-Ming Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27240464%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Sheng-Wei Lin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27240464%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Po-Huang Liang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27240464%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

language of work or name

English

0 references

publication date

12 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27240464%20AND%20SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry

3 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27240464%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27240464%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27240464%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

3035-3042

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27240464%20AND%20SRC:MED&resulttype=core&format=json

Recent developments on coronavirus main protease/3C like protease inhibitors.

3 April 2020

cites work

1 reference

12 December 2020

Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase

1 reference

12 December 2020

The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.

1 reference

12 December 2020

Screening of FDA-Approved Drugs for Treatment of Emerging Pathogens

1 reference

12 December 2020

Mechanisms and enzymes involved in SARS coronavirus genome expression

1 reference

12 December 2020

Anti-SARS coronavirus agents: a patent review (2008 - present).

1 reference

12 December 2020

From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses

1 reference

12 December 2020

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate

1 reference

12 December 2020

Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery

1 reference

12 December 2020

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection

1 reference

12 December 2020

Human infection with a novel avian-origin influenza A (H7N9) virus

1 reference

12 December 2020

Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure

1 reference

12 December 2020

The changing nature of avian influenza A virus (H5N1).

1 reference

12 December 2020

Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.

1 reference

12 December 2020

Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors

1 reference

12 December 2020

Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitors

1 reference

12 December 2020

Individual and common inhibitors of coronavirus and picornavirus main proteases

1 reference

12 December 2020

Viral replicase gene products suffice for coronavirus discontinuous transcription

1 reference

12 December 2020

Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture

1 reference

12 December 2020

Identification, synthesis, and evaluation of new neuraminidase inhibitors

1 reference

12 December 2020

Mechanism of the maturation process of SARS-CoV 3CL protease

1 reference

12 December 2020

Therapies for coronaviruses. Part 2: Inhibitors of intracellular life cycle.

1 reference

12 December 2020

Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy

1 reference

12 December 2020

10.1016/J.BMC.2016.05.013

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27240464%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27240464%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

PubMed publication ID

27240464

1 reference